A carregar...
Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients
BACKGROUND: Aliskiren was shown to increase adverse events in patients with diabetes and concomitant renin–angiotensin blockade. We aim to investigate the efficacy and safety of aliskiren in patients with diabetes and increased cardiovascular risk or established cardiovascular disease. METHODS: MEDL...
Na minha lista:
| Publicado no: | Diab Vasc Dis Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600262/ https://ncbi.nlm.nih.gov/pubmed/28844155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164117715854 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|